CEO Spotlight: Carsten Thiel, Biopharmaceutical Expert and President of Europe at EUSA Pharma

CEOSpotlight: Carsten Thiel, Biopharmaceutical Expert and President of Europe at EUSA Pharma

Carsten Thiel is a biopharmaceutical expert with over 25 years experience in the commercial pharmaceutical industry. Holding a PhD in Molecular Biology and Biochemistry, he has contributed to countless medical advancements throughout his career, particularly in the fields of oncology and rare diseases.

Revealing Secrets through a Lifetime of Lessons with Carsten Thiel

Revealing Secrets through a Lifetime of Lessons with Carsten Thiel

Throughout the lengthy span of a professional career, countless hours are spent participating in a melee of activities, problem solving within extenuating circumstances, and developing the skills needed to excel in a variety of situations. Working professionals sometimes find themselves in unfamiliar territory, requiring critical thinking skills, intuitive action, and swift judgment to navigate the uncharted waters that are often associated with professional endeavors.

Biopharma Expert Carsten Thiel: 40%-60% of Socially Active People to Get Coronavirus

Biopharma Expert Carsten Thiel: 40%-60% of Socially Active People to Get Coronavirus

Carsten Thiel, President of European Commercialization, EUSA Pharma By CorpGov Staff In recent months, the Center for Disease Control and Prevention (CDC) announced the outbreak of a public health emergency of international concern – also known as the disease labeled COVID-19, or the Coronavirus. Coronaviruses

EUSA Pharma Names Industry Veterans to Newly Created Posts

EUSA Pharma names industry veterans to newly-created posts

UK and USA-based specialty drugmaker EUSA Pharma today announced the strengthening of its senior leadership… To continue reading The Pharma Letter please login, subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space.

Curating a Career: Carsten Thiel’s Purposeful Exploration of Pharma

Curating a Career: Carsten Thiel’s Purposeful Exploration of Pharma – Doug Sandler Blog

Through an average career cycle, one can ebb and flow with the change of tides, finding themselves accidentally in various positions. With just enough sheer luck, one may even find advancement in a given field, acquiring just enough knowledge, insight, and experience required to perform all required

Carsten Thiel: People on The Move – New York Business Journal

Carsten Thiel | People on The Move – New York Business Journal

Newly appointed President Europe of rapidly expanding global specialized pharmaceutical giant EUSA, which focuses on treatment and cure of rare diseases and oncology care, Carsten Thiel brings over twenty years of pertinent experience within the pharmaceutical sector to his new role.

Carsten Thiel: Impactful Medicine

(UPDATED) Carsten Thiel: Impactful Medicine – Medical Daily Times

As a visionary within the realm of biotechnology, Carsten Thiel, President of Europe for EUSA Pharma, his leadership, expertise, and professional experience has been parlayed into the successful launch of various high-profile medical products, such as Strensiq, Prolia, Vectibix and Neulasta.

EUSA Pharma Announces Appointment of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development

EUSA Pharma Announces Appointment of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development | Markets Insider

HEMEL HEMPSTED, England and BOSTON, May 15, 2019 /PRNewswire/ — EUSA Pharma (EUSA), a global biopharmaceutical company focused on oncology and rare disease, today announced the strengthening of its senior leadership team with the appointments of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development.